Wedbush Sees Nearly 30% Upside In ProNAi Therapeutics, Initiates At Outperform
August 10, 2015 at 10:38 AM EDT
In a report published Monday, Wedbush analyst David M. Nierengarten initiated coverage of ProNAi Therapeutics Inc (NASDAQ: DNAI) with ...